Thomas J. Polascik, MD

Articles by Thomas J. Polascik, MD

Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright

May 14th 2021

Thomas J. Polascik, MD, reflects on a manuscript written by his colleagues regarding the use of focal therapy to treat localized prostate cancer.

Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other

ByLaurence Klotz, MD, FRCSC, CM,Thomas J. Polascik, MD

November 15th 2014

Investigators and physicians caring for the spectrum of prostate cancer should have a targeted treatment option available for patients who would benefit by it.

Thomas J. Polascik, MD

Articles by Thomas J. Polascik, MD

Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright

Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other

Latest Updated Articles

Trending on CancerNetwork

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

Zenocutuzumab Earns FDA National Priority Voucher in Cholangiocarcinoma

Cevostamab May Fill Gap in Multiple Myeloma Armamentarium